CD133 expression: a potential prognostic marker for non-small cell lung cancers

被引:0
|
作者
Hidenori Mizugaki
Jun Sakakibara-Konishi
Junko Kikuchi
Jun Moriya
Kanako C. Hatanaka
Eiki Kikuchi
Ichiro Kinoshita
Satoshi Oizumi
Hirotoshi Dosaka-Akita
Yoshihiro Matsuno
Masaharu Nishimura
机构
[1] Hokkaido University School of Medicine,First Department of Medicine
[2] Hokkaido University Hospital,Department of Surgical Pathology
[3] Hokkaido University Graduate School of Medicine,Department of Medical Oncology
关键词
CD133; Non-small cell lung cancer; Immunohistochemical assessment; Prognostic marker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:254 / 259
页数:5
相关论文
共 50 条
  • [21] CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma
    Mitsuo Shimada
    Koji Sugimoto
    Shuichi Iwahashi
    Tohru Utsunomiya
    Yuji Morine
    Satoru Imura
    Tetsuya Ikemoto
    Journal of Gastroenterology, 2010, 45 : 896 - 902
  • [22] Expression of the stem cell marker CD133 in malignant meningioma
    Maier, Andrea D.
    Mirian, Christian
    Bartek, Jiri, Jr.
    Juhler, Marianne
    Bartkova, Jirina
    Broholm, Helle
    Mathiesen, Tiit, I
    CLINICAL NEUROPATHOLOGY, 2021, 40 (03) : 151 - 159
  • [23] Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer
    Nakamura, Mitsuhiro
    Kyo, Satoru
    Zhang, Bo
    Zhang, Xiuzhi
    Mizumoto, Yasunari
    Takakura, Masahiro
    Maida, Yoshiko
    Mori, Noriko
    Hashimoto, Manabu
    Ohno, Satoshi
    Inoue, Masaki
    HUMAN PATHOLOGY, 2010, 41 (11) : 1516 - 1529
  • [24] B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis
    Xu, Yue-Hua
    Zhang, Guang-Bo
    Wang, Jia-Min
    Hu, Hua-Cheng
    SAUDI MEDICAL JOURNAL, 2010, 31 (09) : 980 - 986
  • [25] Overexpression of PROM1 (CD133) confers poor prognosis in non-small cell lung cancer
    Qiu, Zhi-Xin
    Zhao, Shuang
    Mo, Xian-Ming
    Li, Wei-Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 6589 - U1683
  • [26] CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer
    Hilbe, W
    Dirnhofer, S
    Oberwasserlechner, F
    Schmid, T
    Gunsilius, E
    Hilbe, G
    Wöll, E
    Kähler, CM
    JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (09) : 965 - 969
  • [27] Overexpression Of Prom1 (cd133) Confers Poor Prognosis In Non-Small Cell Lung Cancer
    Qiu, Z. -X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [28] Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer
    Su, Chunxia
    Xu, Ying
    Li, Xuefei
    Ren, Shengxiang
    Zhao, Chao
    Hou, Likun
    Ye, Zhiwei
    Zhou, Caicun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5509 - 5518
  • [29] The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
    Alamgeer, Muhammad
    Ganju, Vinod
    Szczepny, Anette
    Russell, Prudence A.
    Prodanovic, Zdenka
    Kumar, Beena
    Wainer, Zoe
    Brown, Tracey
    Schneider-Kolsky, Michal
    Conron, Matthew
    Wright, Gavin
    Watkins, D. Neil
    THORAX, 2013, 68 (12) : 1095 - 1104
  • [30] Prognostic value of CD133 expression in stage I lung adenocarcinomas
    Woo, Tetsukan
    Okudela, Koji
    Mitsui, Hideaki
    Yazawa, Takuya
    Ogawa, Nobuo
    Tajiri, Michihiko
    Yamamoto, Taketsugu
    Rino, Yasushi
    Kitamura, Hitoshi
    Masuda, Munetaka
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2011, 4 (01): : 32 - 42